Patent details
EP2490720 Title: ANTI-GCC ANTIBODY MOLECULES AND RELATED COMPOSITIONS AND METHODS
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- EP2490720
- WO Application Number:
- US2010053686
- Type:
- European Patent Granted for NL
- Status:
- Patent in Force
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP10825726.2
- WO Publication Number:
- WO2011050242
- EPO Publication Language:
- English
- SPC Number:
- First Applicant Residence Country:
- United States of America (US)
- Publications:
Dates
- Filing date:
- 22/10/2010
- Grant date:
- 12/02/2020
- EP Publication Date:
- 29/08/2012
- WO Publication Date:
- 28/04/2011
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- 07/05/2020
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 12/02/2020
- EP B1 Publication Date:
- 12/02/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 21/10/2030
- Lapsed By Expiration Date:
- Patent Validated Date:
- 15/05/2020
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 01/04/2022
- Name:
- Amgen British Columbia
- Address:
- 7990 Enterprise Street, Burnaby, BC V5A 1V7, Canada (CA)
- From:
- 01/04/2022
- Name:
- Takeda Pharmaceutical Company Limited
- Address:
- 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, Japan (JP)
Historical Applicant/holder
- From:
- 12/02/2020
- To:
- 01/04/2022
- Name:
- Millennium Pharmaceuticals, Inc.
- Address:
- 40 Landsdowne Street, CAMBRIDGE, MA 02139, United States of America (US)
- From:
- 12/02/2020
- To:
- 01/04/2022
- Name:
- Amgen British Columbia
- Address:
- 7990 Enterprise Street, Burnaby, BC V5A 1V7, Canada (CA)
Agent
- Name:
- ir. M.F.J.M. Ketelaars c.s.
- From:
- 14/05/2020
- Address:
- NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
- To:
Inventor
1
- Name:
- NAM, Samuel, S.
- Address:
- Haverhill, MA 01832, United States of America (US)
2
- Name:
- GREENFIELD, Edward, A.
- Address:
- Stoughton, MA 02072, United States of America (US)
3
- Name:
- BABCOOK, John
- Address:
- Vancouver, BC V6R 2R2, Canada (CA)
4
- Name:
- O'KEEFE, Theresa
- Address:
- Waltham, MA 02453, United States of America (US)
5
- Name:
- QIN, Shixin
- Address:
- Lexington, MA 02421, United States of America (US)
Priority
- Priority Patent Number:
- 254474 P
- Priority Date:
- 23/10/2009
- Priority Country:
- United States of America (US)
Classification
- IPC or IDT classification:
- A61K 39/395; C07K 16/30;
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Journal edition number:
- 17/22
- Publication date:
- 29/04/2022
- Description:
- Changes in the Netherlands Patent Register
2
- Bulletin Heading:
- EP3
- Journal edition number:
- 21/20
- Publication date:
- 20/05/2020
- Description:
- European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
3
- Bulletin Heading:
- EP2
- Journal edition number:
- 07/20
- Publication date:
- 12/02/2020
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
- Issue number:
- 202007
- Publication date:
- 12/02/2020
- Description:
- Grant (B1)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC202200798A
- Date Registered:
- 01/04/2022
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- Baker & McKenzie Amsterdam N.V.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
1
- Name:
- Amgen British Columbia
- Address:
- 7990 Enterprise Street, Burnaby, BC V5A 1V7, Canada (CA)
2
- Name:
- Takeda Pharmaceutical Company Limited
- Address:
- 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, Japan (JP)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- 31/10/2024
- Grace Period End Date:
- 30/04/2025
- Annual Fee Number:
- 15
- Annual Fee Amount:
- 900 Euro
- Penalty Fee Amount:
- 450 Euro
- Last Annual Payment Date:
- 22/09/2023
- Last Annual Fee Paid Number:
- 14
- Last Annual Fee Paid Amount:
- 800 Euro
- Payer:
- Anaqua Services
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 14/05/2020 | Outgoing Correspondence | Letter no formal defects | 1 | /5/7/7/3/1/0800513775/docs/ep10825726.2_0_344212l271.pdf | ||
| 07/05/2020 | Claims | First filed claims | 4 | /5/7/7/3/1/0800513775/docs/ep10825726.2_1_claims20200507084602348.pdf |